Cantor Fitzgerald Reiterates Overweight on Eli Lilly, Maintains $630 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Eli Lilly (NYSE:LLY) and maintained a price target of $630.
November 17, 2023 | 7:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen reaffirms an Overweight rating on Eli Lilly with a steady price target of $630, indicating a positive outlook on the stock.
The reiteration of an Overweight rating and a high price target by a reputable analyst like Louise Chen suggests a strong vote of confidence in Eli Lilly's stock performance. This could lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100